Evolving Trends in 30,427 Surgical Cases of Colorectal Cancer (2008–2023): Assessing the Role of Endoscopic Screening on Case Complexity and the Benefits of Minimally Invasive Techniques - Top-Institutions - MDSpire

Evolving Trends in 30,427 Surgical Cases of Colorectal Cancer (2008–2023): Assessing the Role of Endoscopic Screening on Case Complexity and the Benefits of Minimally Invasive Techniques

  • By

  • Zhenting Lu

  • Junzhe Tang

  • Shiqi Hu

  • Dakui Luo

  • Xinyi Wang

  • Xinxiang Li

  • Qingguo Li

  • April 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Colorectal Surgery
    • Oncology
    • Gastroenterology
    • Minimally Invasive Surgery

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Colorectal Surgery
    • Oncology
    • Gastroenterology
    • Minimally Invasive Surgery

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Colorectal Surgery
    • Oncology
    • Gastroenterology
    • Minimally Invasive Surgery

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Colorectal Surgery
    • Oncology
    • Gastroenterology
    • Minimally Invasive Surgery

  • #5

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Colorectal Surgery
    • Oncology
    • Gastroenterology
    • Minimally Invasive Surgery

Original Source(s)

Evolving Trends in 30,427 Surgical Cases of Colorectal Cancer (2008–2023): Assessing the Role of Endoscopic Screening on Case Complexity and the Benefits of Minimally Invasive Techniques

  • by Zhenting Lu, Junzhe Tang, Shiqi Hu, Dakui Luo, Xinyi Wang, Xinxiang Li, Qingguo Li

  • April 20, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Biotech exec Jeremy Levin on the industry’s strategic turning point